RecruitingNCT04919980
TWIST-EFS
TVMR With the INNOVALVE System Trial - Early Feasibility Study
AI Description
Study to evaluate the safety and performance of the INNOVALVE system
- Who can join
- adult, older adult
- Participants
- 65
- Expected completion
- 2031-07-01
- Funded by
- industry
Conditions studied
Mitral Valve Regurgitation (Degenerative or Functional)
What is being tested
- DEVICE: INNOVALVE system
What it measures
- Absence of implant or delivery related serious adverse events at 30 Days, Absence of implant or delivery related serious adverse events, 30 days
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Ascension Saint Thomas Hospital
Nashville, TN
Cedars-Sinai Medical Center
Los Angeles, CA
Cleveland Clinic
Cleveland, OH
Emory University Hospital Midtown
Atlanta, GA
Hospital of the University of Pennsylvania
Philadelphia, PA
Mayo Clinic (Rochester, Minnesota)
Rochester, MN
Morristown Medical Center
Morristown, NJ
Naples Comprehensive Health (NCH)
Naples, FL
NewYork-Presbyterian Hospital
New York, NY
Northwestern Memorial Hospital
Chicago, IL
OhioHealth Riverside Methodist Hospital
Columbus, OH
OHSU Hospital
Portland, OR
Piedmont Atlanta Hospital
Atlanta, GA
Saint Luke’s Hospital of Kansas City
Kansas City, MO
Sandra Atlas Bass Heart Hospital at North Shore University Hospital
Manhasset, NY
Stanford Health Care
Stanford, CA
Swedish Cherry Hill Campus
Seattle, WA
University of Michigan Health System
Ann Arbor, MI
Vanderbilt University Medical Center
Nashville, TN
Registry entry updated 2026-05-28
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.